Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $78.17 (+35.8%) * Over Last 12-Mos
Rating Score: 4.1 / 10   Percentile Rank: 38%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
11/18/2015 Goldman Sachs New Coverage Neutral
(N/A)
65.00
(N/A)
61.32 57.56 -6.13% Details
9/22/2015 Barclays New Coverage Equalweight
(N/A)
60.00
(N/A)
50.20 57.56 14.66% Details
Like ISIS Ratings? Also take a look at SNY, SAN, BIIB, GILD

ISIS Ratings News